Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tellgen
Shanghai, Shanghai, Chinatellgencorp.com ↗
- Ownership
- Private
- Employees
- ~574
- Development stage
- Other
01
Overview
Tellgen is a leading Chinese developer and manufacturer of in vitro diagnostic reagents and instruments. Its product portfolio covers tumor marker detection, HPV testing, ToRCH products, Y chromosome microdeletion tests, and advanced immunoassay systems. The company’s TESMI platform enables high-throughput multiplex immunoassays for clinical laboratories. It is publicly traded in China with a strong domestic market presence and some international sales.
- Therapeutic areas
- Infectious DiseasesMen's HealthOncology
- Modalities
- Diagnostic kitDevice (IVD platforms)
- Industry
- Molecular Diagnostics
02
Partnerships
Luminex Corp.
Beyond the preview
Go deeper on Tellgen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tellgen.